Clinical Trial Update: Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and tolerability of CTX-4430 has completed. The trial investigated CTX-4430 in pulmonary inflammation and was sponsored by Celtax…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Inflammation

Drugs mentioned

• CTX-4430

Snippet

Sponsor: Celtaxsys, Inc. | Conditions: Pulmonary Inflammation | Phase 1 | Status: COMPLETED